This Week’s CGT News: Duchenne Gene Therapy Hits Pivotal Mark - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

This Week’s CGT News: Duchenne Gene Therapy Hits Pivotal Mark

REGENXBIO reports phase III AAV data in Duchenne; plus: adenoviral immunotherapy, preconditioning-free CAR-T, in vivo immune programming, and DNA-guided CRISPR

  • May 25, 2026

  • 7 min

Share

Original Source(s)

This Week’s CGT News: Duchenne Gene Therapy Hits Pivotal Mark

  • May 25, 2026

Related Content

Comparative Safety of Overactive Bladder Treatments—Unexpected Results in Context

Faster Genomic Testing for Children With Cancer

How could a three-day diagnostic turnaround for all pediatric patients with suspected cancer improve care?

Estimating the costs of capnography within a complete nasogastric tube verification pathway